Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG and Interferon in Superficial Transitional Carcinoma of the Urinary Bladder
NCT00539773Phase 2Completed
- Sponsor
- King Faisal Specialist Hospital and Research Centre
- Start
- Sep 2007
- Primary completion
- Sep 2013
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 2 trial of bcg vaccine in transitional cell carcinoma of the bladder (TCC), sponsored by King Faisal Specialist Hospital and Research Centre. Started Sep 2007; status: completed.
02
Drugs
bcg vaccine
03
Conditions
transitional cell carcinoma of the bladder (TCC)
Beyond the preview
Go deeper on NCT00539773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00539773.